The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines
ERVS
1 other identifier
observational
2,260
1 country
1
Brief Summary
This study is designed to estimate the changes in the etiology and epidemiology of acute gastroenteritis in children aged less than 18 years after the implementation of rotavirus vaccine in the Estonian national immunization program in July 2014.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 14, 2016
CompletedFirst Posted
Study publicly available on registry
January 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedDecember 21, 2016
December 1, 2016
3.5 years
January 14, 2016
December 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The impact of rotavirus vaccination on hospitalizations due to acute gastroenteritis
Evaluate the impact of rotavirus vaccination on hospitalizations due to acute gastroenteritis
up to 2 years
Secondary Outcomes (1)
The severity of disease according to Vesikari and Clark severity scales
up to 2 years
Other Outcomes (3)
The prevalence of rotavirus, adenovirus, astrovirus, norovirus G1, G2 and sapovirus gastroenteritis in Estonia after the implementation of rotavirus vaccine
up to 2 years
Rotavirus genotypes
up to 2 years
Intussusception
up to 2 years
Study Arms (1)
Hospitalized AGE patients
Children less than 18-years-old hospitalized due to acute gastroenteritis to seven Estonian hospitals participating in this study
Eligibility Criteria
All children less than 18-years-old hospitalized due to acute gastroenteritis to seven Estonian hospitals participating in this study from 02.2015-09.2016
You may qualify if:
- children aged \< 18 year
- hospitalized due to acute gastroenteritis
You may not qualify if:
- children aged \> 18 years
- gastroenteritis due to known non-infectious causes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Microbiology, University of Tartu
Tartu, 50411, Estonia
Related Publications (1)
Koivumagi K, Soeorg H, Toompere K, Kallas E, Joegeda EL, Lass E, Huik K, Lutsar I; RV Study group. Rotavirus Strain Surveillance in Estonia After Introduction of Rotavirus Universal Mass Vaccination. Pediatr Infect Dis J. 2021 May 1;40(5):489-494. doi: 10.1097/INF.0000000000003039.
PMID: 33847298DERIVED
Biospecimen
Fecal samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Irja Lutsar, PhD
Institute of Microbiology, University of Tartu
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
January 14, 2016
First Posted
January 25, 2016
Study Start
February 1, 2015
Primary Completion
August 1, 2018
Study Completion
August 1, 2020
Last Updated
December 21, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share